Gurpreet Sidhu, MD
Interventional Cardiology · Chester, NJNPI 1255641163
Payments from drug & device makers
Across 445 payments — averaging $36.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Cardiovascular Systems Inc.$7K
- Abbott$4K
- Medtronic$868
- Amgen$773
- Boston Scientific$529
- Novartis$439
- plus $2K from 28 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Cardiovascular Systems Inc. | 107 | $7,018 |
| Abbott | 84 | $3,986 |
| Medtronic(2 entities) | 22 | $868 |
| Amgen | 45 | $773 |
| Boston Scientific | 10 | $529 |
| Novartis | 37 | $439 |
| AstraZeneca | 21 | $404 |
| Johnson & Johnson | 34 | $358 |
| Merck | 11 | $184 |
| Chiesi USA, Inc. | 6 | $166 |
| Pfizer | 11 | $164 |
| Atricure, Inc. | 2 | $161 |
| Sanofi-aventis U.S. LLC | 7 | $115 |
| Amarin Pharma, Inc. | 8 | $115 |
| Stryker | 1 | $110 |
| E.r. Squibb & Sons, L.L.C. | 7 | $103 |
| Arbor Pharmaceuticals, Inc. | 5 | $68 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 2 | $62 |
| Bayer | 2 | $49 |
| Kiniksa Pharmaceuticals International, PLC | 3 | $48 |
| Abiomed | 2 | $45 |
| Esperion Therapeutics, Inc. | 3 | $44 |
| Shockwave Medical, Inc | 1 | $44 |
| Biosense Webster, Inc. | 1 | $38 |
| Novo Nordisk | 2 | $35 |
| Penumbra, Inc. | 2 | $33 |
| Althera Pharmaceuticals LLC | 2 | $32 |
| Cvrx, Inc. | 1 | $17 |
| Smith+Nephew | 1 | $17 |
| Boehringer Ingelheim | 1 | $16 |
| Portola Pharmaceuticals, LLC | 1 | $15 |
| Regeneron Healthcare Solutions, Inc. | 1 | $15 |
| AbbVie | 1 | $15 |
| Cardinal Health 200 LLC | 1 | $14 |
How this compares
$16,100 in reported general payments places this provider in the 65th percentile of 166 interventional cardiology providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other interventional cardiology in Chester
- Dinesh SingalSomerset$1.4M
- Ankitkumar PatelGlen Ridge$717K
- Matthew SayboltEatontown$671K
- Jaffar RazaSecaucus$537K
- Kintur SanghviBordentown$467K
- Ziad AbbudOcean$361K
- Ramin HastingsHasbrouck Heights$355K
- Ryan KapleHackensack$280K
- Haroon FarazTeaneck$269K
- Darshan GodkarCedar Knolls$260K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.